Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,995 | 94,430 | 14,450 | 35,497 | 49,635 |
| TOTAL | $68,354 | $97,896 | $16,047 | $37,854 | $51,255 |
| Non-Current Assets | |||||
| PPE Net | 30 | 12 | 16 | 28 | N/A |
| Investments And Advances | 0 | 0 | 0 | 0 | 50 |
| Other Non-Current Assets | 110 | 219 | 0 | 85 | 0 |
| TOTAL | $140 | $231 | $16 | $112 | $50 |
| Total Assets | $68,494 | $98,127 | $16,063 | $37,966 | $51,306 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,533 | 1,452 | 2,383 | 936 | 1,826 |
| Accrued Expenses | 5,375 | 1,189 | 1,809 | 2,216 | 1,207 |
| TOTAL | $8,020 | $2,748 | $4,192 | $3,208 | $3,033 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 112 | 0 | 0 | 0 |
| TOTAL | $N/A | $112 | $N/A | $N/A | $N/A |
| Total Liabilities | $8,020 | $2,861 | $4,192 | $3,208 | $3,033 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 91,879 | 89,704 | 15,966 | 15,966 | 15,966 |
| Common Shares | 92 | 90 | 16 | 16 | 16 |
| Retained earnings | -130,903 | -94,780 | -68,055 | -44,090 | -29,254 |
| TOTAL | $60,474 | $95,266 | $11,871 | $34,758 | $48,272 |
| Total Liabilities And Equity | $68,494 | $98,127 | $16,063 | $37,966 | $51,306 |